Association of TERT promoter mutations with early recurrence in hepatocellular carcinoma: a subgroup analysis in a Vietnamese cohort
Open Access
- 28 April 2026
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Abstract
Telomerase reverse transcriptase (TERT) promoter mutation is among the most frequent genetic alterations in hepatocellular carcinoma (HCC), closely associaKeywords
All Related Versions
Funding Information
- Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam
This publication has 34 references indexed in Scilit:
- A systematic analysis with the hierarchical cluster analysis strategy on the complex interaction of TERT and CTNNB1 somatic mutations in Vietnamese hepatocellular carcinoma patientsGene, 2024
- Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trialThe Lancet, 2023
- Global burden of primary liver cancer in 2020 and predictions to 2040Journal of Hepatology, 2022
- TERT promoter mutations and melanoma survival: A comprehensive literature review and meta-analysisCritical Reviews in Oncology/Hematology, 2021
- Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter RegionHepatology, 2019
- Non-alcoholic Fatty Liver Disease and Metabolic Syndrome—Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of GastroenterologyJournal of Clinical and Experimental Hepatology, 2015
- TERT promoter mutations: Gatekeeper and driver of hepatocellular carcinomaJournal of Hepatology, 2014
- TERT promoter mutation in resectable hepatocellular carcinomas: A strong association with hepatitis C infection and absence of hepatitis B infectionInternational Journal of Surgery, 2014
- Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell linesNature Medicine, 1997
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995